ATE428116T1 - Verfahren zur identifizierung wahrend der apoptose modifizierter proteine - Google Patents

Verfahren zur identifizierung wahrend der apoptose modifizierter proteine

Info

Publication number
ATE428116T1
ATE428116T1 AT06026484T AT06026484T ATE428116T1 AT E428116 T1 ATE428116 T1 AT E428116T1 AT 06026484 T AT06026484 T AT 06026484T AT 06026484 T AT06026484 T AT 06026484T AT E428116 T1 ATE428116 T1 AT E428116T1
Authority
AT
Austria
Prior art keywords
modified proteins
proteins during
during apoptosis
identifying modified
identifying
Prior art date
Application number
AT06026484T
Other languages
English (en)
Inventor
Thomas Rudel
Bernd Thiede
Nikolaus Machuy
Original Assignee
Rudel Thomas Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00112813A external-priority patent/EP1164374A1/de
Application filed by Rudel Thomas Dr filed Critical Rudel Thomas Dr
Application granted granted Critical
Publication of ATE428116T1 publication Critical patent/ATE428116T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Electrochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06026484T 2000-06-16 2001-06-15 Verfahren zur identifizierung wahrend der apoptose modifizierter proteine ATE428116T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00112813A EP1164374A1 (de) 2000-06-16 2000-06-16 Verfahren zur Identifizierung während der Apoptose modifizierter Proteine
EP00125013 2000-11-16

Publications (1)

Publication Number Publication Date
ATE428116T1 true ATE428116T1 (de) 2009-04-15

Family

ID=26071055

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06026484T ATE428116T1 (de) 2000-06-16 2001-06-15 Verfahren zur identifizierung wahrend der apoptose modifizierter proteine

Country Status (6)

Country Link
US (1) US20040022779A1 (de)
EP (2) EP1764616B1 (de)
AT (1) ATE428116T1 (de)
AU (1) AU2001266070A1 (de)
DE (1) DE60138321D1 (de)
WO (1) WO2001096873A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060199946A1 (en) 2003-04-21 2006-09-07 Hideaki Shimada Apoptosis inducing agent and method for inducing apoptosis
DE102010048899B8 (de) * 2010-10-19 2012-06-14 Universitätsklinikum Schleswig-Holstein Campus Lübeck Verfahren zum Diagnostizieren aneuploider kolorektaler Tumore
WO2013192298A1 (en) * 2012-06-22 2013-12-27 The Scripps Research Institute Apoptosis biomarkers
HRP20191860T1 (hr) 2013-03-13 2019-12-27 Forma Therapeutics, Inc. Derivati 2-hidroksi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etan-1-ona i srodni spojevi kao inhibitori sintaze masnih kiselina (fasn) za liječenje raka
KR101909906B1 (ko) * 2015-11-13 2018-10-22 한양대학교 산학협력단 비강 투여를 통한 뇌졸중 치료용 조성물
CN110475853A (zh) * 2017-01-13 2019-11-19 益福生医股份有限公司 新颖乳酸菌及其应用
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
WO2020092395A1 (en) 2018-10-29 2020-05-07 Forma Therapeutics, Inc. SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL116026A (en) * 1994-11-22 2005-08-31 Rhone Poulenc Rorer Sa Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
US6156535A (en) * 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
EP0924296A3 (de) * 1997-12-03 2001-08-01 Leadd B.V. Verfahren un Mittteln für die Induktion von Apoptosis durch Interferenz in RNS-Prozessierung
EP1080233A4 (de) * 1998-05-18 2003-02-05 Apoptosis Technology Inc Verbindungen, untersuchungsverfahren und verwendungen die anti-apoptotische gene und genprodukte beinhalten
FR2780062B1 (fr) * 1998-06-17 2000-07-28 Rhone Poulenc Rorer Sa Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations

Also Published As

Publication number Publication date
EP1290446A2 (de) 2003-03-12
EP1764616B1 (de) 2009-04-08
EP1764616A3 (de) 2007-03-28
WO2001096873A3 (en) 2002-04-25
US20040022779A1 (en) 2004-02-05
AU2001266070A1 (en) 2001-12-24
DE60138321D1 (de) 2009-05-20
EP1764616A2 (de) 2007-03-21
WO2001096873A2 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
DE50115863D1 (de) Verfahren zur regelung der fahrstabilität
DE69904754D1 (de) Verfahren zur bioanalyse
DE60139614D1 (de) Verfahren zur s.i.p/h.323-zusammenarbeit
DE50011437D1 (de) Verfahren zur Erzeugung von Justiermarken
DE69817839D1 (de) Verfahren zur erhöhung der photosynthese
DE60212193D1 (de) Verfahren zur verbesserung der reproduktionsleistung bei geflügel
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
DE69838689D1 (de) Verfahren zur Aktualisierung von Konten
DE50015014D1 (de) Verfahren zur Hydroformylierung von Olefinen
DE50102926D1 (de) Verfahren zur oxidation von kohlenwasserstoffen
DE60011540D1 (de) Verfahren zur Desinfektion von Kontaktlinsen
ATE244231T1 (de) Verfahren zur epoxidierung von olefinen
ATE257482T1 (de) Verfahren zur stabilisierung von siloxan- verbindungen
DE60124884D1 (de) Verfahren zur verbesserung der fotomaskengeometrie
ATE291567T1 (de) Verfahren zur herstellung von nitroxymethylphenylestern von aspirinderivaten
ATE472733T1 (de) Verfahren zur beurteilung von zellulären proliferativen erkrankungen
DE69811943D1 (de) Verfahren zur markierung von kontaktlinsenverpackungen
DE50303241D1 (de) Verfahren zur bereitstellung von abwesenheitsinformation
DE50104426D1 (de) Verfahren zur vernetzung von polyacrylaten
ATE378307T1 (de) Verfahren zur gewinnung von cetamin-enantiomeren.
DE60138321D1 (de) Verfahren zur Identifizierung während der Apoptose modifizierter Proteine
DE60032077D1 (de) Verfahren zur dehalogenierung von kohlenwasserstoffhaltigen kohlenstoff-kohlenstoff doppelbindungen
DE59713035D1 (de) Verfahren zur Regelung der Leistungsverstärkung
ATE242772T1 (de) Verfahren zur herstellung von hiv-protease inhibitoren
ATE274599T1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties